Genetics Generation Advancement Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 139.69 million compared to TWD 120.21 million a year ago. Net income was TWD 10.74 million compared to net loss of TWD 0.463 million a year ago. Basic earnings per share from continuing operations was TWD 0.44 compared to basic loss per share from continuing operations of TWD 0.02 a year ago. Diluted earnings per share from continuing operations was TWD 0.44 compared to diluted loss per share from continuing operations of TWD 0.02 a year ago.